TALPHERA, INC. Noncash or Part Noncash Acquisition, Payables Assumed
TALPHERA, INC. (TLPH) reported Noncash or Part Noncash Acquisition, Payables Assumed of $0 for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionPayablesAssumed1 · last filed 2023-05-10
- TALPHERA, INC. noncash or part noncash acquisition, payables assumed for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- TALPHERA, INC. noncash or part noncash acquisition, payables assumed for the quarter ending 2022-03-31 was $531.00K.
- TALPHERA, INC. noncash or part noncash acquisition, payables assumed for the quarter ending 2021-03-31 was $0.00.
| Period end | Noncash or Part Noncash Acquisition, Payables Assumed 3 month |
|---|---|
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 |
| 2022-03-31 | $531.00K 10-Q · filed 2023-05-10 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |